Skip to content

A Device to Prevent Sudden Unexpected Death in Epilepsy: Detecting Peri-Ictal Body Position

A Device to Prevent Sudden Unexpected Death in Epilepsy: Detecting Peri-Ictal Body Position

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06135285
Enrollment
50
Registered
2023-11-18
Start date
2026-08-15
Completion date
2027-06-01
Last updated
2026-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Brief summary

The goal of this study is to assess the performance of a commercial sheet sensor in determining body position after generalized tonic-clonic (GTC) seizures. If a sheet sensor could accurately detect GTC seizures, this could be a step towards autonomously repositioning patients with the aid of a smart mattress. Primary Objective Milestones: Feasibility objective: Monitor 50 patients with the objective of capturing at least 20 GTCS events. Primary analytic objective: Achieve detection of anatomical landmarks with body position change within 5 seconds with an accuracy of 75% both interictally and post-GTCS. Secondary Objective Detect the postictal prone position with an accuracy of 100%.

Detailed description

This is an exploratory study with the goal of using a commercial bed sheet sensor and software with Soterya Inc's Korus software to identify GTCs in an inpatient setting. 50 patients will be monitored at the BWH EMU with the goal of capturing 20 GTCS events. The sheet sensor used will be the Sensor Products Tactilus High Performance Mattress Sensor System with the accompanying Tactilus Software. Pressure sensor data will be processed by Soterya Inc's Korus Software. The sensor system is a piezoresistive device that is already in commercial use.

Interventions

The subject will be monitored as they lie on the Tactilus Bodyfitter sensor.

Sponsors

Brigham and Women's Hospital
Lead SponsorOTHER
Soterya Inc.
CollaboratorUNKNOWN

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1\. Adults 18 years of age or older admitted to the BWH EMU with drug-resistant epilepsy, defined by the failure of at least two anti-seizure medications and a documented history of electroclinical seizures

Exclusion criteria

1. Suspicion of functional dissociative seizures (psychogenic nonepileptic seizures) 2. Patients admitted for medication adjustment only

Design outcomes

Primary

MeasureTime frameDescription
Body position detection5 secondsCorrect detection of one of 4 cardinal body positions: prone, supine, left, right
Number of subjects correctly repositioned from the prone to recovery position30 secondsWe will measure the performance of Korus to successfully reposition the subject from the prone to recovery position

Countries

United States

Contacts

CONTACTJong Woo Lee, MD, PhD
jlee38@bwh.harvard.edu617-732-7547
PRINCIPAL_INVESTIGATORJong Woo Lee, MD, PhD

Brigham and Women's Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 28, 2026